UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000006207
Receipt number R000007339
Scientific Title Molecular alterations in Barrett's esophagus by the treatment with proton pump inhibitors or Helicobacter pylori eradication
Date of disclosure of the study information 2011/08/21
Last modified on 2015/02/22 13:17:34

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Molecular alterations in Barrett's esophagus by the treatment with proton pump inhibitors or Helicobacter pylori eradication

Acronym

Molecular alterations in Barrett's esophagus and the treatment with PPIs or H. pylori eradication

Scientific Title

Molecular alterations in Barrett's esophagus by the treatment with proton pump inhibitors or Helicobacter pylori eradication

Scientific Title:Acronym

Molecular alterations in Barrett's esophagus and the treatment with PPIs or H. pylori eradication

Region

Japan


Condition

Condition

Barrett's esophagus

Classification by specialty

Gastroenterology

Classification by malignancy

Others

Genomic information

YES


Objectives

Narrative objectives1

To clarify the molecular alterations in Barrett's esophagus by the treatment with PPIs or H. pylori eradication

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Changes of biomarkers related to pathogenesis of Barrett's esophagus are evaluated at baseline and 1-yr after intervention with/without PPI administration in H. pylori negative patients and H. pylori eradication in H. pylori positive patients

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit


Blinding

Open -no one is blinded

Control

No treatment

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

4

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

H. pylori un-eradicated group (H. pylori positive case)

Interventions/Control_2

H. pylori eradicated group (H. pylori positive case)

Interventions/Control_3

PPI un-treated group (H. pylori negative case)

Interventions/Control_4

PPI treated group (H. pylori negative case)

Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients with Barrett's esophagus diagnosed by endoscopy

Key exclusion criteria

(1)Patients with malignancy in other organs
(2)Patients with having allergy to PPIs or drugs used for H. pylori eradication
(3)Patients who are regularly taking PPIs or non-steroidal anti-inflammatory drugs
(4)Past episode of H. pylori treatment
(5)Patients with having a past history of esophagectomy or gastrectomy
(6)Patients who have determined by the physicians to have any reasons of unqualified

Target sample size

38


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Hiroto Miwa

Organization

Hyogo College of Medicine

Division name

Division of Gastroenterology, Department of Internal Medicine

Zip code


Address

1-1 Mukogawa-cho, Nishinomiya, Hyogo

TEL

0798-45-6665

Email

miwahgi@hyo-med.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Jiro Watari

Organization

Hyogo College of Medicine

Division name

Division of Gastroenterology, Department of Internal Medicine

Zip code


Address

1-1 Mukogawa-cho, Nishinomiya, Hyogo

TEL

0798-45-6662

Homepage URL


Email

watarij@hyo-med.ac.jp


Sponsor or person

Institute

Division of Gastroenterology, Department of Internal Medicine, Hyogo College of Medicine

Institute

Department

Personal name



Funding Source

Organization

Japan Society for the Promotion of Science

Organization

Division

Category of Funding Organization

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

兵庫医科大学病院(兵庫県)


Other administrative information

Date of disclosure of the study information

2011 Year 08 Month 21 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2010 Year 07 Month 01 Day

Date of IRB


Anticipated trial start date

2010 Year 07 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2011 Year 08 Month 21 Day

Last modified on

2015 Year 02 Month 22 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000007339


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name